🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Video-guided Versus Conventional Right-sided Double-Lumen Tubes for One-Lung Ventilation in Thoracoscopic Surgery

RecruitingNAAges 18 Years - anyAllDiansan Su
NCT07362797 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This multicentre randomised controlled trial compares a video-guided right-sided double-lumen tube with a conventional right-sided double-lumen tube in adults undergoing elective thoracoscopic surgery requiring one-lung ventilation. The video-guided tube incorporates an integrated camera that provides continuous airway visualisation during initial placement and intraoperative monitoring. Participants will be randomly assigned in a 1:1 ratio to receive one of the two tubes. Final tube position after initial placement will be confirmed by fibreoptic bronchoscopy in both groups. During one-lung ventilation, additional fibreoptic bronchoscopy will be performed only when clinically indicated or according to predefined rescue criteria. The primary outcome is successful initial right-sided double-lumen tube placement. Secondary outcomes include right upper-lobe bronchial obstruction, intraope

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
\*\*Inclusion Criteria:\*\* 1. Adults aged 18 years or older. 2. American Society of Anesthesiologists physical status I-III. 3. Scheduled for elective thoracoscopic surgery requiring one-lung ventilation with a right-sided double-lumen tube. 4. Able to provide written informed consent. \*\*Exclusion Criteria:\*\* 1. Contraindication to placement of a right-sided double-lumen tube, including a lesion involving the right main bronchus that precludes its use. 2. Known tracheobronchial anatomical abnormality that may interfere with right-sided double-lumen tube placement or lung isolation. 3. Known or anticipated difficult airway. 4. Requirement for rapid-sequence induction. 5. Emergency surgery. 6. Severe respiratory instability that, in the investigator's judgement, makes participation unsafe. 7. Concurrent participation in another interventional clinical trial that could interfere with the present study.
💊

What it tests

  • Video-guided right-sided double-lumen tube
  • Conventional right-sided double-lumen tube
📍

Where

3 sites
The First Affiliated Hospital, Zhejiang University School of Medicine,
Hangzhou, China
Affiliated Hospital of Jiaxing University（The First Hospital of Jiaxing）
Jiaxing, China
The Second Affiliated Hospital of Jiaxing University（The Second Hospital of Jiaxing）
Jiaxing, China
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy